3.36% -0.49

Enanta Pharmaceuticals Inc (ENTA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Enanta Pharmaceuticals Inc-Aktie (ENTA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-03-31	2024-12-31	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	24.72% 18.61	14.93	16.96	17.97	17.05
Operating Expenses	24.29% 29.87	39.45	40.50	42.16	49.82
Benefits Costs and Expenses	21.47% 30.53	38.88	39.66	41.02	48.57
Costs And Expenses	24.29% 29.87	39.45	40.50	42.16	49.82
Depreciation and Amortization	2.24% 1.23	1.203	0.889	0.594	0.621
Operating Income/Loss	54.12% -11.25	-24.53	-23.54	-24.18	-32.77
Nonoperating Income/Loss	214.36% -0.661	0.578	0.837	1.132	1.246
Income/Loss From Continuing Operations Before Tax	50.25% -11.91	-23.95	-22.71	-23.05	-31.52
Income Tax Expense/Benefit	101.84% 0.024	-1.305	-0.416	-0.395	-0.363
Income/Loss From Continuing Operations After Tax	47.28% -11.94	-22.64	-22.29	-22.66	-31.16
Net Income/Loss	47.28% -11.94	-22.64	-22.29	-22.66	-31.16
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	34.62% 28.75	21.36	21.24	21.18	21.17
Diluted Average Shares	34.62% 28.75	21.36	21.24	21.18	21.17
Basic Earnings Per Share	60.38% -0.42	-1.06	-1.05	-1.07	-1.47
Diluted Earnings Per Share	60.38% -0.42	-1.06	-1.05	-1.07	-1.47
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.87

0.18%

ROIV

$28.99

1.33%

MRNA

$54.07

1.61%

BNTX

$90.20

0.16%

INSM

$139.44

0.28%

ONC

$288.30

0.99%